Skip to main content
editorial
. 2014 Mar 24;4(1):1–17. doi: 10.5500/wjt.v4.i1.1

Table 2.

Anti-antibodies main drugs to date in use and mechanism of action

Steps Cells or mechanisms involved Drugs Mechanism of action
Exposure to antigen B Cells Rituximab ivig Binds CD20 on B cells and mediates cell lysis Multiple B cell apoptosis, decrease in B-cell proliferation
Secretion of alloantibodies Plasma cells; antibodies Bortezomib Decrease donor-specific alloantibody production Mechanical removal of alloantibodies
Plasma- exchange ivig Multiple B cell apoptosis, decrease in B-cell proliferation
Binding of antibodies to the graft Complement activation Eculizumab Blocks cleavage of terminal complement C5 and halts the process of complement-mediated cell destruction